Cargando…

Biomarkers in Rare Demyelinating Disease of the Central Nervous System

Rare neurological diseases are a heterogeneous group corresponding approximately to 50% of all rare diseases. Neurologists are among the main specialists involved in their diagnostic investigation. At the moment, a consensus guideline on which neurologists may base clinical suspicion is not availabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boziki, Marina, Sintila, Styliani-Aggeliki, Ioannidis, Panagiotis, Grigoriadis, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665127/ https://www.ncbi.nlm.nih.gov/pubmed/33182495 http://dx.doi.org/10.3390/ijms21218409

Ejemplares similares

Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
por: Bakirtzis, Christos, et al.
Publicado: (2023)

The Role of Diet and Interventions on Multiple Sclerosis: A Review
por: Stoiloudis, Panagiotis, et al.
Publicado: (2022)

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis
por: Boziki, Marina, et al.
Publicado: (2022)

Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center
por: Boziki, Marina, et al.
Publicado: (2021)

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases
por: Sintila, Styliani-Aggeliki, et al.
Publicado: (2023)

CNS Ageing in Health and Neurodegenerative Disorders
por: Kesidou, Evangelia, et al.
Publicado: (2023)

Editorial: Complement in nervous system disease
por: Michailidou, Iliana, et al.
Publicado: (2023)

Signaling through the S1P−S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment
por: Chatzikonstantinou, Simela, et al.
Publicado: (2021)

A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination
por: Boziki, Marina, et al.
Publicado: (2021)

Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018)

The Role of Extracellular Vesicles in Demyelination of the Central Nervous System
por: López-Guerrero, José Antonio, et al.
Publicado: (2020)

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2016)

Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
por: Boziki, Marina, et al.
Publicado: (2022)

Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough
por: Häusler, Darius, et al.
Publicado: (2019)

Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2021)

Citation classics in central nervous system inflammatory demyelinating disease
por: Kim, Jee‐Eun, et al.
Publicado: (2017)

Demyelinating Disease of the Central Nervous System Concurrent With COVID-19
por: Karsidag, Sibel, et al.
Publicado: (2021)

Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
por: Linker, Ralf A, et al.
Publicado: (2009)

Imaging Central Nervous System Demyelination and Remyelination by Positron-Emission Tomography
por: Bodini, Benedetta, et al.
Publicado: (2016)

Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents
por: Kesidou, Evangelia, et al.
Publicado: (2017)

Prevention, Intervention and Care of Neurodegenerative Diseases
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Central nervous system Listeria monocytogenes infection mimicking central nervous system idiopathic inflammatory demyelinating disease
por: Xu, Rui, et al.
Publicado: (2019)

Central nervous system inflammatory demyelinating disorders of childhood
por: Kamate, Mahesh, et al.
Publicado: (2010)

The role of interleukin-6 in central nervous system demyelination
por: Petković, Filip, et al.
Publicado: (2016)

From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases
por: Dubois-Dalcq, Monique, et al.
Publicado: (2008)

Pregnancy-Related Immune Changes and Demyelinating Diseases of the Central Nervous System
por: Qiu, Ke, et al.
Publicado: (2019)

Central nervous system demyelinating diseases: glial cells at the hub of pathology
por: Coutinho Costa, Vinicius Gabriel, et al.
Publicado: (2023)

Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system
por: Ishido, Hideaki, et al.
Publicado: (2023)

FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis
por: Zhang, Qingxiang, et al.
Publicado: (2023)

Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy
por: Chen, Di, et al.
Publicado: (2020)

Comment on: Central nervous system inflammatory demyelinating disorders of childhood
por: Radhakrishna, H.
Publicado: (2011)

HCV-Related Central and Peripheral Nervous System Demyelinating Disorders
por: Mariotto, Sara, et al.
Publicado: (2014)

Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system
por: Gonzalez, Ginez A., et al.
Publicado: (2016)

Coronavirus infects and causes demyelination in primate central nervous system
por: Murray, Ronald S., et al.
Publicado: (1992)

Efficacy and Safety of Rituximab in Central Nervous System Demyelinating Disorders
por: Patil, Varsha A., et al.
Publicado: (2021)

Genetic Basis of Inflammatory Demyelinating Diseases of the Central Nervous System: Multiple Sclerosis and Neuromyelitis Optica Spectrum
por: Ortiz, Genaro Gabriel, et al.
Publicado: (2023)

The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System
por: Bello-Morales, Raquel, et al.
Publicado: (2020)

Oxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases
por: Gkekas, Ioannis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7vo1mu9jju8bcnmib7gvtafobs